Vincenzo Cerundolo is Professor of Immunology in the Nuffield Department of Clinical Medicine at the University of Oxford. He has made central contributions to our understanding of the human immune response. His first major contribution led to the discovery that a peptide transporter known as TAP was located in the major histocompatability complex, and essential for the presentation of peptide antigens to T lymphocytes. From there he moved to tumour immunity and his work on identifying T cell responses to melanoma has led to phase-one clinical trials of vaccination for the treatment of melanoma.
FellowBack to directory listing
Professor Vincenzo Cerundolo FRS FMedSci
Director, MRC Human Immunology Unit
Radcliffe Department of Medicine
University of Oxford
analysis of innate and antigen specific T-cell responses in health and diseaseSection committee elected by
Genetics, cellular and developmental biology, microbiology and immunology